Afuco™ Anti-Human A33 ADCC Therapeutic Antibody (KRN330), ADCC Enhanced
Anti-A33 ADCC Enhanced Antibody (KRN330) is an ADCC enhanced antibody produced by our Afuco™ platform. KRN330 is a recombinant, fully-human monoclonal antibody directed against A33, a surface differentiation antigen on normal colonic epithelium, which is uniformly expressed in 95% of colorectal cancers.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-002CL |
Pricing | Inquiry |
Host | Human |
Target | A33 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | 4°C or -20°C, avoid repeated freezing and thawing. |